Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-16-006881

Options or other derivatives

  • CEO, PRESIDENT acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jaksch Frank L Jr · CEO, PRESIDENT

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-08-15 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +85,000 85,000 D
Loading xslF345X03/form4-08172016_010831.xml…